ProfileGDS4718 / AFFX-HUMGAPDH/M33197_3_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]14.8473100
GSM549102patient 115, normal, homogenized [OPG study]14.8426100
GSM549104patient 119, normal, homogenized [OPG study]14.7555100
GSM549108patient 138, normal, homogenized [OPG study]14.8249100
GSM549119patient 077, normal, homogenized [OPG study]14.8186100
GSM549133patient 032, cancer, homogenized [OPG study]14.7578100
GSM549139patient 042, cancer, homogenized [OPG study]14.7033100
GSM549099patient 107, normal, homogenized [OPG study]14.7683100
GSM549109patient 139, normal, homogenized [OPG study]14.8125100
GSM549110patient 046, normal, homogenized [OPG study]14.7804100
GSM549114patient 063, normal, homogenized [OPG study]14.6757100
GSM549122patient 082, normal, homogenized [OPG study]14.8373100
GSM549134patient 033, cancer, homogenized [OPG study]14.6324100
GSM549136patient 036, cancer, homogenized [OPG study]14.7072100
GSM549140patient 044, cancer, homogenized [OPG study]14.7099100
GSM549111patient 047, normal, homogenized [OPG study]14.7527100
GSM549113patient 057, normal, homogenized [OPG study]14.6949100
GSM549132patient 031, cancer, homogenized [OPG study]14.7684100
GSM549137patient 038, cancer, homogenized [OPG study]14.6477100
GSM549142patient 047, cancer, homogenized [OPG study]14.8589100
GSM549100patient 110, normal, homogenized [OPG study]14.7433100
GSM549107patient 135, normal, homogenized [OPG study]14.7886100
GSM549115patient 068, normal, homogenized [OPG study]14.746100
GSM549116patient 072, normal, homogenized [OPG study]14.7638100
GSM549120patient 078, normal, homogenized [OPG study]14.8362100
GSM549131patient 030, cancer, homogenized [OPG study]14.5767100
GSM549118patient 074, normal, homogenized [OPG study]14.82100
GSM549129patient 027, cancer, homogenized [OPG study]14.8945100
GSM549123patient 088, normal, homogenized [OPG study]14.8354100
GSM549124patient 006, cancer, homogenized [OPG study]14.7509100
GSM549126patient 015, cancer, homogenized [OPG study]14.6985100
GSM549128patient 025, cancer, homogenized [OPG study]14.7529100
GSM549103patient 117, normal, homogenized [OPG study]14.8433100
GSM549117patient 073, normal, homogenized [OPG study]14.7532100
GSM549138patient 041, cancer, homogenized [OPG study]14.6935100
GSM549141patient 045, cancer, homogenized [OPG study]14.5814100
GSM549130patient 028, cancer, homogenized [OPG study]14.7466100
GSM549101patient 111, normal, homogenized [OPG study]14.8026100
GSM549105patient 128, normal, homogenized [OPG study]14.8079100
GSM549106patient 134, normal, homogenized [OPG study]14.7044100
GSM549112patient 048, normal, homogenized [OPG study]14.7693100
GSM549125patient 011, cancer, homogenized [OPG study]14.7911100
GSM549127patient 024, cancer, homogenized [OPG study]14.7985100
GSM549135patient 035, cancer, homogenized [OPG study]14.6702100